Results 91 to 100 of about 4,689 (214)

Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings

open access: yesInternational Journal of Methods in Psychiatric Research, Volume 35, Issue 2, June 2026.
ABSTRACT Objectives For English, the validated part of Psychedelic Experience Scale (PES48) is a four‐factor structure called the Mystical Experience Questionnaire (MEQ30). The other validated part of the PES48 consists of four more factors: two more mystical factors (paradoxicality and connectedness, which together with the MEQ30 form the MEQ40), and ...
Kurt Stocker   +8 more
wiley   +1 more source

The identification and determination of lysergic acid diethylamide in narcotic seizures

open access: yes, 1964
Methods are described by which lysergic acid diethylamide (LSD) can be identified and determined in the presence of heroin, other narcotics and controlled drugs.
K Genest, C G Farmilo
core   +1 more source

Analytically Confirmed Opioid Detections From the Emerging Drugs Network of Australia

open access: yesEmergency Medicine Australasia, Volume 38, Issue 3, June 2026.
ABSTRACT Objective We describe analytically confirmed opioid‐related presentations to emergency departments (EDs) in Australia. Methods Presentations with analytically confirmed opioid exposure, between January 2021 and December 2024, were identified from the Emerging Drugs Network of Australia (EDNA) Clinical Registry.
J. Soderstrom   +53 more
wiley   +1 more source

ENTHEOGENS, MYSTICISM, AND NEUROSCIENCE

open access: yesZygon, 2014
Entheogens or psychedelic drugs such as lysergic acid diethylamide (LSD) and psilocybin are associated with mystical states of experience. Drug laws currently limit research, but important new work is under way at major biomedical research facilities ...
doaj   +2 more sources

Return of the lysergamides. Part VI:Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD)

open access: yes, 2020
Lysergic acid diethylamide (LSD) is a prototypical serotonergic psychedelic drug and the subject of many clinical investigations. In recent years, a range of lysergamides has emerged with the production of some being inspired by the existing scientific ...
Folker Westphal   +27 more
core   +1 more source

Acute effects of lysergic acid diethylamide in healthy subjects [PDF]

open access: yes, 2015
After no research in humans for >40 years, there is renewed interest in using lysergic acid diethylamide (LSD) in clinical psychiatric research and practice.
Vollenweider, Franz X   +22 more
core   +1 more source

Does LSD confer lasting psychological resilience? an investigation of naturalistic users experiencing job loss.

open access: yesPLoS ONE
Recent studies on classic psychedelics have suggested that their use is associated with psychological strengths and resilience, thereby conferring users a type of psychological protection relative to non-users.
Benjamin A Korman
doaj   +1 more source

Serotonergic hallucinogens and recognition of facial emotion expressions: a systematic review of the literature

open access: yesTherapeutic Advances in Psychopharmacology, 2019
Background: Recognition of emotions in facial expressions (REFE) is a key aspect of social cognition. Anxiety and mood disorders are associated with deficits in REFE, and anxiolytics and antidepressants reverse these deficits.
Juliana M. Rocha   +6 more
doaj   +1 more source

Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects [PDF]

open access: yes, 2017
Background and Objective: Lysergic acid diethylamide (LSD) is used recreationally and in clinical research. The aim of the present study was to characterize the pharmacokinetics and exposure–response relationship of oral LSD.
Katharina M. Rentsch   +17 more
core   +1 more source

Home - About - Disclaimer - Privacy